Additive effects of exogenous IL-12 supplementation and antibiotic treatment in infection prophylaxis.
Additive effects of exogenous IL-12 supplementation and antibiotic treatment in infection prophylaxis.
复制标题
DOI:
10.1002/jor.21520
复制
发表时间:
2012-02
影响因子:
2.8
通讯作者:
Li, Bingyun
中科院分区:
文献类型:
--
作者:
Boyce, Brandon M.;Lindsey, Brock A.;Clovis, Nina B.;Smith, E. Suzanne;Hobbs, Gerald R.;Hubbard, David F.;Emery, Sanford E.;Barnett, John B.;Li, Bingyun
The increasing clinical incidence and host risk of open fracture-associated infections, as well as the reduced effectiveness of conventional antibiotics to treat such infections, have driven the development of new therapies for the prophylaxis of open fracture-associated infections. We investigated percutaneous supplementation of a natural cytokine (i.e. interleukin 12p70 or IL-12) at an open fracture site to reduce open fracture-associated infections. We also determined the efficacy of the combination therapy of IL-12 and conventional antibiotic therapy in the prophylaxis of open fracture-associated infections. An open femur fracture infection model was produced by direct inoculation of a clinical isolate of Staphylococcus aureus after creating a femur fracture using rats. The animals were assigned to one of four groups: no drug administration, percutaneous supplementation of IL-12, intraperitoneal administration of the antibiotic ampicillin, or percutaneous IL-12 in combination with intraperitoneal ampicillin. Animals were euthanized at post-operative days 6, 10, 14, and 21. Percutaneous IL-12 led to a reduction in infection at post-operative days 6 and 10. For the first time, exogenous IL-12 was found to have additive effects in the prevention of infection when combined with conventional treatment (i.e. antibiotic therapy). Combination therapy of ampicillin and IL-12 substantially reduced the infection rate at post-operative day 6 and also decreased the time needed for complete inhibition of infection. Therefore, exogenous IL-12, providing a mechanism of protection independent of antibiotic resistance, complements the routine use of antibiotics.
登录
查看更多内容
影响因子:
4.1
作者:
Lucke, M;Wildemann, B;Schmidmaier, G
通讯作者:
Schmidmaier, G
影响因子:
3
作者:
Bonville CA;Percopo CM;Dyer KD;Gao J;Prussin C;Foster B;Rosenberg HF;Domachowske JB
通讯作者:
Domachowske JB
影响因子:
14
作者:
Li, Bingyun;Jiang, Bingbing;Boyce, Brandon M.;Lindsey, Brock A.
通讯作者:
Lindsey, Brock A.
影响因子:
3
作者:
Brune, IB;Wilke, W;Siewert, JR
通讯作者:
Siewert, JR
影响因子:
5.7
作者:
Flohe, Stefanie B.;Agrawal, Hemant;Schade, F. Ulrich
通讯作者:
Schade, F. Ulrich